Join NSF's Robyn Meurant at the BIVDA Near Patient Testing Working Party in London
Interest in Near Patient Testing (NPT) continues to gain momentum as it has a major role to play in redesigning services around the needs of the patient. Robyn Meurant will participate in the Near Patient Testing working group on November 14, as it aims to understand the current market for near patient testing and identify the challenges that are likely to impair progress in this exciting area. The group has recently published a document highlighting the value of near patient testing and the significant benefits of wider adoption to patient outcomes.
The British In Vitro Diagnostics Association (BIVDA) is the national industry association for companies with major involvement and interest in the in vitro diagnostics (IVD) industry. BIVDA represents over 95% of IVD manufacturers and distributors in the UK, from British start-up companies to UK subsidiaries of multinational corporations. BIVDA members currently employ over 8,500 people in the UK, with a total industry turnover of approximately £820 million.